To explore the relationship among age, frailty, and clinical outcomes, including mortality rates and length of hospital stay, in middle-aged and older adults hospitalized due to hMPV infections.
Key Findings:
Among 212 patients, 85.4% had severe disease and 61.3% were frail.
Frail patients exhibited higher rates of severe disease (80.8% vs. 63.4%) and longer hospital stays (median 8 vs. 4 days).
Significant associations with severe disease included frailty (OR 1.99, 95% CI), cardiac illness (OR 1.76, 95% CI), congestive heart failure (OR 1.91, 95% CI), and COPD (OR 1.93, 95% CI).
Interpretation:
Frailty is a significant predictor of severe hMPV infections in older adults, underscoring the necessity for its recognition in clinical management and vaccination strategies.
Limitations:
Data limited to hospitalized patients, potentially underrepresenting the overall burden of hMPV.
Study conducted in specific Canadian provinces, which may limit generalizability.
Potential biases in data collection may affect the findings.
Conclusion:
Recognizing frailty in clinical settings is crucial as hMPV vaccines are developed, emphasizing the need for targeted prevention strategies in vulnerable populations and highlighting areas for future research.
by Henrique Pott, Jason J LeBlanc, May ElSherif, Todd F Hatchette, Melissa K Andrew, Shelly A McNeil, on behalf of the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network
